CX Institutional Acquires 340 Shares of Colgate-Palmolive (NYSE:CL)

CX Institutional boosted its holdings in Colgate-Palmolive (NYSE:CLFree Report) by 8.1% in the fourth quarter, HoldingsChannel reports. The firm owned 4,539 shares of the company’s stock after purchasing an additional 340 shares during the period. CX Institutional’s holdings in Colgate-Palmolive were worth $413,000 at the end of the most recent quarter.

Other institutional investors have also recently added to or reduced their stakes in the company. MBB Public Markets I LLC boosted its stake in Colgate-Palmolive by 1,530.9% during the second quarter. MBB Public Markets I LLC now owns 56,414 shares of the company’s stock worth $5,474,000 after acquiring an additional 52,955 shares in the last quarter. The Manufacturers Life Insurance Company boosted its position in shares of Colgate-Palmolive by 6.1% during the 2nd quarter. The Manufacturers Life Insurance Company now owns 697,209 shares of the company’s stock worth $67,657,000 after purchasing an additional 39,838 shares in the last quarter. Legal & General Group Plc grew its stake in shares of Colgate-Palmolive by 0.8% in the 2nd quarter. Legal & General Group Plc now owns 7,785,101 shares of the company’s stock valued at $755,465,000 after buying an additional 61,413 shares during the period. Susquehanna Fundamental Investments LLC bought a new stake in Colgate-Palmolive in the 2nd quarter valued at about $2,125,000. Finally, Kathmere Capital Management LLC raised its stake in Colgate-Palmolive by 23.7% during the 2nd quarter. Kathmere Capital Management LLC now owns 11,804 shares of the company’s stock worth $1,145,000 after buying an additional 2,265 shares during the period. 80.41% of the stock is owned by institutional investors and hedge funds.

Insider Activity at Colgate-Palmolive

In other Colgate-Palmolive news, CFO Stanley J. Sutula III sold 45,410 shares of the business’s stock in a transaction on Tuesday, November 5th. The stock was sold at an average price of $94.11, for a total value of $4,273,535.10. Following the sale, the chief financial officer now directly owns 36,726 shares in the company, valued at $3,456,283.86. The trade was a 55.29 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through the SEC website. 0.34% of the stock is owned by company insiders.

Analyst Upgrades and Downgrades

Several equities research analysts have recently commented on CL shares. StockNews.com downgraded Colgate-Palmolive from a “buy” rating to a “hold” rating in a report on Thursday, January 9th. Wells Fargo & Company lowered their price objective on shares of Colgate-Palmolive from $92.00 to $83.00 and set an “underweight” rating on the stock in a report on Tuesday, January 7th. Barclays reduced their price objective on shares of Colgate-Palmolive from $96.00 to $83.00 and set an “equal weight” rating for the company in a report on Friday, January 17th. UBS Group lowered their target price on shares of Colgate-Palmolive from $112.00 to $104.00 and set a “buy” rating on the stock in a report on Thursday, January 16th. Finally, JPMorgan Chase & Co. decreased their price objective on Colgate-Palmolive from $109.00 to $103.00 and set an “overweight” rating for the company in a report on Thursday, January 16th. One analyst has rated the stock with a sell rating, ten have issued a hold rating and twelve have given a buy rating to the company. According to MarketBeat.com, the stock presently has a consensus rating of “Hold” and an average target price of $101.11.

Read Our Latest Analysis on Colgate-Palmolive

Colgate-Palmolive Stock Performance

NYSE CL opened at $87.88 on Friday. The company has a market capitalization of $71.79 billion, a PE ratio of 25.18, a price-to-earnings-growth ratio of 3.59 and a beta of 0.44. The company has a debt-to-equity ratio of 9.46, a quick ratio of 0.68 and a current ratio of 1.04. Colgate-Palmolive has a 52-week low of $80.03 and a 52-week high of $109.30. The company has a 50-day simple moving average of $91.81 and a 200 day simple moving average of $97.44.

Colgate-Palmolive Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Friday, February 14th. Investors of record on Tuesday, January 21st will be issued a $0.50 dividend. The ex-dividend date of this dividend is Tuesday, January 21st. This represents a $2.00 dividend on an annualized basis and a dividend yield of 2.28%. Colgate-Palmolive’s dividend payout ratio (DPR) is presently 57.31%.

Colgate-Palmolive Company Profile

(Free Report)

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.

Recommended Stories

Want to see what other hedge funds are holding CL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Colgate-Palmolive (NYSE:CLFree Report).

Institutional Ownership by Quarter for Colgate-Palmolive (NYSE:CL)

Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.